Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov-Dec;13(6):955-961.
doi: 10.1016/j.jceh.2023.05.006. Epub 2023 May 25.

Hepatic Steatosis After Partial Pancreatectomy in a Cohort of Patients with Intraductal Papillary Mucinous Neoplasm

Zhenteng Li  1   2 , Jonathan Weinstein  2   3 , Ellen Redstone  1   2 , Donald G Mitchell  2
Affiliations

Hepatic Steatosis After Partial Pancreatectomy in a Cohort of Patients with Intraductal Papillary Mucinous Neoplasm

Zhenteng Li et al. J Clin Exp Hepatol. 2023 Nov-Dec.

Abstract

Background/aims: Nonalcoholic fatty liver disease (NAFLD) has been observed in patients after partial pancreatectomy. Previous studies have been performed on oncologic patients who underwent partial pancreatectomy and received adjuvant chemotherapy. By studying a cohort of patients with intraductal papillary mucinous neoplasms (IPMNs) who did not receive chemotherapy, the authors investigate the isolated effect of partial pancreatectomy on the development of fatty liver.

Methods: A retrospective search for patients with pancreatic IPMNs who underwent partial pancreatectomy at an academic center from 2006 to 2014 identified 63 patients, including 42 who had pancreaticoduodenectomy (PD) and 21 who had distal pancreatectomy (DP). Fourteen patients with preoperative hepatic steatosis, diabetes, obesity, on steroid therapy, history of malignancy, or incomplete data were excluded. No patient received chemotherapy. Liver fat signal fraction (LFSF) was computed by the Dixon method using pre- and postoperative in- and out-of-phase MRI.

Results: Of the 49 patients included in the study, 29 (59%) underwent PD and 20 (41%) underwent DP. A total of 17 patients (34%) developed fatty liver after surgery. The entire cohort developed significant weight loss, 72.1 versus 69.4 kg (P < 0.01). Postoperatively, there was significant increase in LFSF, 1.3% versus 9.6% following PD (P < 0.01), and 2.1% versus 9.4% following DP (P = 0.01).

Conclusion: Partial pancreatectomy increases the risk of NAFLD independent of chemotherapy-induced hepatotoxicity. The underlying mechanism remains unclear and possibly related to pancreatic exocrine insufficiency and malnutrition.

Keywords: IPMN; hepatic steatosis; partial pancreatectomy.

PubMed Disclaimer

Figures

Image 1
Graphical abstract
Figure 1
Figure 1
Patient selection.
Figure 2
Figure 2
T1-weighted in-phase (A, B, C) and out-of-phase (D, E, F) images: This is an example of a patient who developed mild hepatic steatosis with liver fat fraction of 8% one year out from pancreaticoduodenectomy (B, E) and 11% after 2 years (C, F). The circles on the images denote the 4 regions of interest used in liver fat fraction computation.
Figure 3
Figure 3
Comparison of varying degree of hepatic steatosis after partial pancreatectomy: pancreaticoduodenectomy vs. distal pancreatectomy. Note that significant proportion of patients developed fatty liver after the operation. Interestingly, the surgical approach, PD or DP, does not affect the outcome of hepatic steatosis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Laffan T.A., Horton K.M., Klein A.P., et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol. 2008;191:802–807. - PMC - PubMed
    1. Zhang X.M., Mitchell D.G., Dohke M., Holland G.A., Parker L. Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology. 2002;223:547–553. - PubMed
    1. Do R.K., Katz S.S., Gollub M.J., et al. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. AJR Am J Roentgenol. 2014;203:973–979. - PMC - PubMed
    1. Tanaka M., Fernandez-del Castillo C., Adsay V., et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–197. - PubMed
    1. Heckler M., Michalski C.W., Schaefle S., Kaiser J., Buchler M.W., Hackert T. The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN - a meta-analysis on their accuracy. Pancreatology. 2017;17:255–262. - PubMed

LinkOut - more resources